α-1b干扰素联合静脉丙球治疗新生儿病毒性肺炎疗效观察  

Therapeutic Effect of α-1b Interferon Combined with Intravenous Propofol in the Treatment of Neonatal Viral Pneumonia

作　　者：刘品[1] LIU Pin(Department of Neonatology,Shenyang Children's Hospital,Shenyang 110000,Liaoning,China)

机构地区：[1]沈阳市儿童医院新生儿科,辽宁沈阳110000

出　　处：《医学信息》2018年第3期142-143,共2页Journal of Medical Information

摘　　要：目的探究α-1b干扰素与静脉丙球联合治疗新生儿病毒性肺炎的临床疗效。方法选择我院儿科2014年12月~2015年12月收治的60例新生儿病毒性肺炎患儿,随机分为联合组和对照组,每组30例。对照组采用抗生素、抗病毒药物、吸氧等常规对症治疗,联合组在对照组基础上采用α-1b干扰素与静脉丙球联合治疗,观察两组患儿的临床治疗效果。结果联合组总有效率为93.33%,明显高于对照组的76.67%,差异有统计学意义(P<0.05)。结论在新生儿病毒性肺炎的常规对症措施基础上,采用α-1b干扰素联合静脉丙球治疗可以优化临床治疗效果,帮助患儿尽早恢复健康,值得临床普及。Objective To investigate the clinical efficacy ofα-1b interferon combined with intravenous propofol in the treatment of neonatal viral pneumonia.Methods From December 2014 to December 2015,60 neonates with viral pneumonia were randomly divided into combined group and control group.30 cases in each group.The control group was treated with antibiotics,antiviral drugs,oxygen inhalation and other routine symptomatic treatment,the combined group was treated with interferonα-1b combined with intravenous propofol on the basis of the control group,and the clinical effect of the two groups was observed.Results The total effective rate of the combined group was 93.33%,significantly higher than 76.67%in the control group,the difference was statistically significant(P<0.05).Conclusion The routine symptomatic treatment of neonatal viral pneumonia based on the use ofα-1b interferon combined with intravenous ball therapy can optimize the clinical treatment effect,to help children recover as soon as possible,worthy of clinical popularity.

关 键 词：Α-1B干扰素 静脉丙球 新生儿病毒性肺炎 

分 类 号：R722.1[医药卫生—儿科]